Yang Shuhao, Wu Haoming, Peng Chao, He Jian, Pu Zhengguang, Lin Zhidong, Wang Jun, Hu Yingkun, Su Qiao, Zhou Bingnan, Yong Xin, Lan Hai, Hu Ning, Hu Xulin
Department of Orthopaedics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Orthopedic Laboratory of Chongqing Medical University, Chongqing, China.
Biomater Transl. 2024 Sep 28;5(3):274-299. doi: 10.12336/biomatertransl.2024.03.005. eCollection 2024.
The treatment and repair of bone tissue damage and loss due to infection, tumours, and trauma are major challenges in clinical practice. Artificial bone scaffolds offer a safer, simpler, and more feasible alternative to bone transplantation, serving to fill bone defects and promote bone tissue regeneration. Ideally, these scaffolds should possess osteoconductive, osteoinductive, and osseointegrative properties. However, the current first-generation implants, represented by titanium alloys, have shown poor bone-implant integration performance and cannot meet the requirements for bone tissue repair. This has led to increased research on second and third generation artificial bone scaffolds, which focus on loading bioactive molecules and cells. Polymer microspheres, known for their high specific surface areas at the micro- and nanoscale, exhibit excellent cell and drug delivery behaviours. Additionally, with their unique rigid structure, microsphere scaffolds can be constructed using methods such as thermal sintering, injection, and microsphere encapsulation. These scaffolds not only ensure the excellent cell drug loading performance of microspheres but also exhibit spatial modulation behaviour, aiding in bone repair within a three-dimensional network structure. This article provides a summary and discussion of the use of polymer microsphere scaffolds for bone repair, focusing on the mechanisms of bone tissue repair and the current status of clinical bone grafts, aimed at advancing research in bone repair.
因感染、肿瘤和创伤导致的骨组织损伤和缺失的治疗与修复是临床实践中的重大挑战。人工骨支架为骨移植提供了一种更安全、更简便且更可行的替代方案,用于填充骨缺损并促进骨组织再生。理想情况下,这些支架应具备骨传导性、骨诱导性和骨整合性。然而,以钛合金为代表的第一代植入物,其骨植入整合性能较差,无法满足骨组织修复的要求。这促使人们对第二代和第三代人工骨支架展开更多研究,这些研究聚焦于负载生物活性分子和细胞。聚合物微球以其在微米和纳米尺度上的高比表面积而闻名,具有出色的细胞和药物递送性能。此外,凭借其独特的刚性结构,可通过热烧结、注射和微球包封等方法构建微球支架。这些支架不仅能确保微球优异的细胞药物负载性能,还展现出空间调制行为,有助于在三维网络结构内进行骨修复。本文对聚合物微球支架用于骨修复的应用进行了总结与讨论,重点关注骨组织修复机制及临床骨移植现状,旨在推动骨修复研究。